CELLINK has been granted a patent for "Cellulose Nanofibrillar Bioink for 3D Bioprinting for Cell Culturing, Tissue Engineering and Regenerative Medicine Applications" from European Patent Office
CELLINK has been granted a patent for its unique cellulose-based bioink technology enabling bioprinting of multiple cell types for tissue engineering and regenerative medicine applications. The patent protection applies to the European market, one of CELLINK’s most important markets.The granted patent from the European Patent Office shows novelty, inventive step, and industrial applicability. This technology is used in CELLINK’s first universal bioink, CELLINK® Bioink, which has expanded into the CELLINK bioink Series (CELLINK® RGD, CELLINK® FIBRIN, CELLINK® SKIN, CELLINK® BONE and CELLINK®
